Phase IIb trial of<i>in vivo</i>electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy
Phase IIb trial of<i>in vivo</i>electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Phase IIb trial of<i>in vivo</i>electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy have?
Phase IIb trial of<i>in vivo</i>electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy has 29 citations in the OpenAlex counts ScholarIQ stores.
When was Phase IIb trial of<i>in vivo</i>electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy published?
Phase IIb trial of<i>in vivo</i>electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy has 2017 year in the ScholarIQ index.
What is the open-access status of Phase IIb trial of<i>in vivo</i>electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy?
Phase IIb trial of<i>in vivo</i>electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy has hybrid oa status in the ScholarIQ index.
What is the DOI of Phase IIb trial of<i>in vivo</i>electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy?
The DOI for Phase IIb trial of<i>in vivo</i>electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy is on the source record.
What is the PMID of Phase IIb trial of<i>in vivo</i>electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy?
The PMID for Phase IIb trial of<i>in vivo</i>electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy is on the source record.
What is the OpenAlex record for Phase IIb trial of<i>in vivo</i>electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy?
The OpenAlex for Phase IIb trial of<i>in vivo</i>electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy is on the source record.